Compare VVOS & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VVOS | BON |
|---|---|---|
| Founded | 2016 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 10.6M |
| IPO Year | 2020 | 2020 |
| Metric | VVOS | BON |
|---|---|---|
| Price | $0.51 | $1.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.75 | N/A |
| AVG Volume (30 Days) | ★ 3.6M | 24.2K |
| Earning Date | 04-15-2026 | 01-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.76 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,443,000.00 | N/A |
| Revenue This Year | $69.66 | $390.73 |
| Revenue Next Year | $48.38 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $0.49 | $1.13 |
| 52 Week High | $7.40 | $3.39 |
| Indicator | VVOS | BON |
|---|---|---|
| Relative Strength Index (RSI) | 33.65 | 44.67 |
| Support Level | N/A | $1.16 |
| Resistance Level | $0.76 | $1.33 |
| Average True Range (ATR) | 0.14 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 5.98 | 20.58 |
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.